SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 183 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,270,000 | +2275.8% | 55,000 | +431.4% | 0.46% | +2455.6% |
| Q1 2017 | $306,000 | +7.7% | 10,350 | 0.0% | 0.02% | -47.1% |
| Q4 2016 | $284,000 | -92.0% | 10,350 | -82.1% | 0.03% | -86.5% |
| Q3 2016 | $3,556,000 | +1170.0% | 57,900 | +293.9% | 0.25% | +769.0% |
| Q2 2016 | $280,000 | -70.7% | 14,700 | -70.0% | 0.03% | -60.8% |
| Q1 2016 | $956,000 | -36.5% | 48,971 | +25.6% | 0.07% | -69.9% |
| Q4 2015 | $1,505,000 | – | 39,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |